RankingsPricing
  1. JP-listed companies
  2. Pharmarise Holdings Corporation
  3. Financials
  4. Income before tax

Pharmarise Holdings CorporationJP:2796

Market cap
¥6.4B
P/E ratio
22.6x
SummaryFinancialsHistorySegmentsOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
May 31, 2025136-83.67%
May 31, 2024833-41.79%
May 31, 20231,431-5.67%
May 31, 20221,517+17.78%
May 31, 20211,288+25.90%
May 31, 20201,023+73.39%
May 31, 2019590-45.97%
May 31, 20181,092+237.04%
May 31, 2017324-50.88%
May 31, 2016660-33.89%
May 31, 2015998-21.57%
May 31, 20141,272+3.59%
May 31, 20131,228-16.48%
May 31, 20121,471+9.49%
May 31, 20111,343

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)